Advanced company searchLink opens in new window

NUCLEOME THERAPEUTICS LIMITED

Company number 12109297

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
25 Nov 2022 RP04AP03 Second filing for the appointment of Phil Boyd as a secretary
14 Nov 2022 SH02 Sub-division of shares on 21 October 2022
14 Nov 2022 SH08 Change of share class name or designation
14 Nov 2022 SH10 Particulars of variation of rights attached to shares
04 Nov 2022 SH01 Statement of capital following an allotment of shares on 21 October 2022
  • GBP 820.3252
  • ANNOTATION Clarification a second filed SH01 was registered on 14/12/2022
01 Nov 2022 RP04AP01 Second filing for the appointment of Rana Al-Hallaq as a director
01 Nov 2022 RP04AP01 Second filing for the appointment of Dr Fiona Caroline Maclaughlin as a director
01 Nov 2022 RP04AP01 Second filing for the appointment of Bauke Anninga as a director
26 Oct 2022 AP01 Appointment of Rana Al-Hallaq as a director on 11 October 2022
  • ANNOTATION Clarification a second filed AP01 was registered on 01/11/2022.
26 Oct 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Re-sub division 11/10/2022
  • RES01 ‐ Resolution of adoption of Articles of Association
26 Oct 2022 MA Memorandum and Articles of Association
25 Oct 2022 PSC05 Change of details for Oxford Science Enterprises Plc as a person with significant control on 11 October 2022
  • ANNOTATION Clarification a second filed PSC05 was registered on 25/11/2022
25 Oct 2022 AP01 Appointment of Dr Fiona Caroline Maclaughlin as a director on 11 October 2022
  • ANNOTATION Clarification a second filed AP01 was registered on 01/11/2022.
25 Oct 2022 AP01 Appointment of Bauke Anninga as a director on 11 October 2022
  • ANNOTATION Clarification a second filed AP01 was registered on 01/11/2022.
25 Oct 2022 AP03 Appointment of Phil Boyd as a secretary on 11 October 2022
  • ANNOTATION Clarification a second filed AP03 was registered on 25/11/2022
21 Oct 2022 AD01 Registered office address changed from Bioescalator Innovation Building University of Oxford Old Road Campus, Roosevelt Dr Oxford OX3 7FZ United Kingdom to Suite C, Second Floor, Schrodinger Building, Oxford Science Park Oxford OX4 4GE on 21 October 2022
29 Jul 2022 CS01 Confirmation statement made on 29 July 2022 with updates
28 Jul 2022 SH01 Statement of capital following an allotment of shares on 29 June 2022
  • GBP 639.4285
22 Dec 2021 AA Accounts for a small company made up to 31 July 2021
28 Oct 2021 PSC05 Change of details for Oxford Sciences Innovation Plc as a person with significant control on 30 September 2021
21 Jul 2021 CS01 Confirmation statement made on 16 July 2021 with no updates
23 Mar 2021 CH01 Director's details changed for Dr Danuta Mariola Jeziorska on 28 August 2019
18 Jan 2021 AA Total exemption full accounts made up to 31 July 2020
17 Dec 2020 AP01 Appointment of Mr Jonathan Paul Hepple as a director on 30 November 2020
17 Dec 2020 CH01 Director's details changed for Dr Danuta Mariola Jeziorska on 30 July 2020